Entity Status. LICENSEE shall have a continuing obligation to keep UNIVERSITY and its patent counsel responsible for the PATENT RIGHTS informed of the entity status (large entity, small entity, and micro entity) of LICENSEE and all its SUBLICENSEES. LICENSEE agrees to give UNIVERSITY prompt notice of a change in any entity status of it or any SUBLICENSEE. A statement or future statement by LICENSEE and/or its SUBLICENSEE as to its entity status constitutes a representation that is subject to indemnity under Section 6.01.
Appears in 5 contracts
Sources: Exclusive License Agreement (Decibel Therapeutics, Inc.), Exclusive License Agreement (Decibel Therapeutics, Inc.), Exclusive License Agreement (Decibel Therapeutics, Inc.)
Entity Status. LICENSEE shall have a continuing obligation to keep UNIVERSITY and its patent counsel responsible for the PATENT RIGHTS informed of the entity status (large entity, small entity, and micro entity) of LICENSEE and all its SUBLICENSEES. LICENSEE ▇▇▇▇▇▇▇▇ agrees to give UNIVERSITY prompt notice of a change in any entity status of it or any SUBLICENSEE. A statement or future statement by LICENSEE and/or its SUBLICENSEE as to its entity status constitutes a representation that is subject to indemnity under Section 6.01.
Appears in 2 contracts
Sources: License Agreement (Solid Biosciences Inc.), Exclusive License Agreement (Decibel Therapeutics, Inc.)
Entity Status. LICENSEE shall have a continuing obligation to keep UNIVERSITY and its patent counsel responsible for the PATENT RIGHTS informed of the entity status (large entity, small entity, and micro entity) of LICENSEE and all its SUBLICENSEES. LICENSEE agrees to give UNIVERSITY prompt notice of a change in any entity status of it or any SUBLICENSEESUBLICENSEES. A statement or future statement by LICENSEE and/or its SUBLICENSEE SUBLICENSEES as to its entity status constitutes a representation that is subject to indemnity under Section 6.01.
Appears in 1 contract
Sources: Exclusive License Agreement (Yield10 Bioscience, Inc.)